KMDAKamada Ltd.

$495M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$127M+11.1% YoY

Gross Profit

$50M39.1% margin

Operating Income

$23M17.9% margin

Net Income

$22M17.5% margin

EPS (Diluted)

$0.57

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

$26M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$174M

Total Liabilities

$38M

Stockholders' Equity

$135M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$127M	$114M	+11.1%
Gross Profit	$50M	$41M	+19.9%
Operating Income	$23M	$19M	+18.3%
Net Income	$22M	$22M	-0.2%

KMDA FY 2019 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena